ONKOLYTISCHE IMMUNTHERAPIEN

Patent europeic · EP3778897 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3778897
Numer da la dumonda
EP20189155
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
22-08-2014
Publitgà
17-02-2021
Concedì
20-12-2023
La protecziun finescha il pli tard
21-08-2034
Proxima taxa annuala scadenta
31-08-2026
Classas IPC
C12N 15/39 (2006.01)
A61K 39/285 (2006.01)
A61K 35/768 (2015.01)
C12N 7/00 (2006.01)
Prioritad
US 201361868978 P 22.08.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-09-2025

    Midada

    Published in Swissreg on 01.09.2025

  2. 30-10-2024

    Midada

    Published in Swissreg on 30.10.2024

  3. 03-09-2024

    Midada

    Published in Swissreg on 03.09.2024

  4. 21-12-2023

    Represchentant inscrit

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 21.12.2023

  5. 20-12-2023

    Concedì

    Published in Swissreg on 20.12.2023

Partidas

Possessur

University of Pittsburgh - Of the Commonwealth System of Higher Education

1st Floor Gardner Steel Conference Center 130 Thackeray Avenue, Pittsburgh, PA 15260, US

Represchentant

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventur

THORNE, Stephen Howard

Pittsburgh, Pennsylvania 15238, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.